Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Baker Hughes A | BKR | 4. oct 2024 | 37.93 | +1.01 |
Ball | BALL | 4. oct 2024 | 66.02 | +1.03 |
Bank Of America | BAC | 4. oct 2024 | 40.11 | +2.19 |
Bank Of New York Mellon | BK | 4. oct 2024 | 71.98 | +1.64 |
Bath & Body Works | BBWI | 4. oct 2024 | 29.92 | +1.18 |
Baxter International | BAX | 4. oct 2024 | 36.32 | +3.53 |
Becton, Dickinson And Co | BDX | 4. oct 2024 | 238.22 | +0.36 |
Berkshire Hathaway B | BRK-B | 4. oct 2024 | 461.97 | +1.99 |
Best Buy | BBY | 4. oct 2024 | 99.61 | +1.45 |
Bio-Rad Laboratories A | BIO | 4. oct 2024 | 343.70 | +1.96 |
Bio-Techne | TECH | 4. oct 2024 | 74.78 | +1.05 |
Biogen | BIIB | 4. oct 2024 | 185.68 | +0.49 |
BlackRock | BLK | 4. oct 2024 | 949.19 | -0.24 |
Blackstone | BX | 4. oct 2024 | 151.92 | +0.48 |
Boeing | BA | 4. oct 2024 | 155.00 | +2.98 |
Booking | BKNG | 4. oct 2024 | 4 187.70 | +2.04 |
BorgWarner | BWA | 4. oct 2024 | 35.13 | +0.86 |
Boston Properties | BXP | 4. oct 2024 | 80.74 | +1.15 |
Boston Scientific | BSX | 4. oct 2024 | 84.54 | +0.86 |
Bristol-Myers Squibb | BMY | 4. oct 2024 | 53.96 | -0.44 |
Broadcom | AVGO | 4. oct 2024 | 176.64 | +2.76 |
Broadridge Financial Solutions | BR | 4. oct 2024 | 215.33 | +0.15 |
Brown & Brown | BRO | 4. oct 2024 | 105.65 | +0.97 |
Brown Forman B | BF-B | 4. oct 2024 | 47.36 | -0.50 |
Builders Firstsource | BLDR | 4. oct 2024 | 192.28 | -1.83 |
Bunge | BG | 4. oct 2024 | 98.17 | +1.55 |
C.H. Robinson Worldwide | CHRW | 4. oct 2024 | 106.73 | +1.17 |
Cadence Design Systems | CDNS | 4. oct 2024 | 268.65 | +1.08 |
Caesars Entertainment | CZR | 4. oct 2024 | 44.47 | +1.41 |
Camden Property Trust | CPT | 4. oct 2024 | 120.86 | +0.07 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.